A share price of Novartis AG ADR [NVS] is currently trading at $111.93, up 1.14%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The NVS shares have gain 3.93% over the last week, with a monthly amount glided 5.14%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Novartis AG ADR [NYSE: NVS] stock has seen the most recent analyst activity on July 19, 2024, when Deutsche Bank downgraded its rating to a Hold. Previously, Goldman started tracking the stock with Buy rating on May 30, 2024, and set its price target to $120. On February 23, 2024, BMO Capital Markets initiated with a Market Perform rating and assigned a price target of $114 on the stock. Morgan Stanley started tracking the stock assigning a Equal-Weight rating and suggested a price target of $114 on January 23, 2024. HSBC Securities downgraded its rating to Hold for this stock on December 18, 2023. In a note dated September 25, 2023, Morgan Stanley upgraded an Equal-Weight rating on this stock.
Novartis AG ADR experienced fluctuations in its stock price throughout the past year between $91.70 and $112.48. Currently, Wall Street analysts expect the stock to reach $113 within the next 12 months. Novartis AG ADR [NYSE: NVS] shares were valued at $111.93 at the most recent close of the market. An investor can expect a potential return of 0.96% based on the average NVS price forecast.
Analyzing the NVS fundamentals
Trailing Twelve Months sales for Novartis AG ADR [NYSE:NVS] were 47.55B which represents -8.15% decline. Gross Profit Margin for this corporation currently stands at 0.74% with Operating Profit Margin at 0.25%, Pretax Profit Margin comes in at 0.23%, and Net Profit Margin reading is 0.34%. To continue investigating profitability, this company’s Return on Assets is posted at 0.17, Equity is 0.39 and Total Capital is 0.17. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.66.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 111.05 points at the first support level, and at 110.17 for the second support level. However, for the 1st resistance point, the stock is sitting at 112.48, and for the 2nd resistance point, it is at 113.02.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Novartis AG ADR [NYSE:NVS] is 0.93. Further, the Quick Ratio stands at 0.72, while the Cash Ratio is 0.29. Considering the valuation of this stock, the price to sales ratio is 4.61, the price to book ratio is 5.43 and price to earnings (TTM) ratio is 14.26.
